EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

21‐Hydroxylase Deficient Congenital Adrenal Hyperplasia Due to Maternal Uniparental Isodisomy

Michelle L Kluge, Lynn Schema, Katy Schroepfer, Emily K Thoreson, Kyriakie Sarafoglou, Ross A Rowsey, Cherisse A Marcou, Ann M Moyer, Matthew J Schultz iD

Case Reports in Endocrinology · 2026-01 · 2026 (1)

DOI: 10.1155/crie/3596318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Endocrinology, online erschienen am 05.06.2026. Verfasst von Michelle L Kluge und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital adrenal hyperplasia (CAH) due to 21‐hydroxylase deficiency (21‐OHD CAH) is an autosomal recessive genetic condition that results from pathogenic variants in the CYP21A2 gene. Noncarrier parents are found in a small percentage of cases, typically due to de novo variants. However, uniparental disomy (UPD) should also be considered. UPD is generally suspected when an individual with an autosomal recessive condition is found to be homozygous for a rare pathogenic variant and consanguinity has been ruled out. However, UPD in CYP21A2 may be hard to recognize because homozygous genotypes are not uncommon. We present the case of a 19‐month‐old male born preterm who presented to pediatric endocrinology after a positive newborn screen for CAH. He was small for gestational age, with a history of adrenal crisis and elevated 17‐hydroxyprogesterone (17‐OHP). Genetic testing revealed homozygosity for two common pathogenic CYP21A2 variants: c.293‐13C >G and c.1360C >T (p.Pro454Ser), both variants were found in the heterozygous state in the mother while the father’s CYP21A2 molecular testing was negative. UPD testing was pursued and the results were consistent with the patient having maternal isodisomy of chromosome 6. In cases of patients with CAH due to homozygous CYP21A2 variants, suspicion for UPD may be increased if the child also presents with intrauterine growth restriction (IUGR), or transient neonatal diabetes (TNDM) mellitus, associated with maternal and paternal UPD of chromosome 6, respectively.

Schlagwörter

Stichwörter der Autor:innen

21-hydroxylase deficient congenital adrenal hyperplasia 21-OHD CAHCYP21A2intrauterine growth restriction IUGRuniparental disomy UPD

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
  • Department of Pediatrics, M Health Fairview University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota, USA.
  • Public Health Laboratory, Minnesota Department of Health, St. Paul, Minnesota, USA, health.state.mn.us.

ORCID-Profile: Matthew J Schultz

Zitieren

APA

Kluge, M. L., Schema, L., Schroepfer, K., Thoreson, E. K., Sarafoglou, K., Rowsey, R. A., Marcou, C. A., Moyer, A. M., & Schultz, M. J. (2026). 21‐Hydroxylase Deficient Congenital Adrenal Hyperplasia Due to Maternal Uniparental Isodisomy. Case Reports in Endocrinology, 2026(1). https://doi.org/10.1155/crie/3596318

Vancouver

Kluge ML, Schema L, Schroepfer K, Thoreson EK, Sarafoglou K, Rowsey RA, et al. 21‐Hydroxylase Deficient Congenital Adrenal Hyperplasia Due to Maternal Uniparental Isodisomy. Case Reports in Endocrinology. 2026;2026(1). doi:10.1155/crie/3596318

BibTeX
@article{Kluge2026,
  author = {Kluge, Michelle L and Schema, Lynn and Schroepfer, Katy and Thoreson, Emily K and Sarafoglou, Kyriakie and Rowsey, Ross A and Marcou, Cherisse A and Moyer, Ann M and Schultz, Matthew J},
  title = {21‐Hydroxylase Deficient Congenital Adrenal Hyperplasia Due to Maternal Uniparental Isodisomy},
  journal = {Case Reports in Endocrinology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crie/3596318}
}
Kostenlos starten →